ScholarIQanswers from OpenAlex

New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice

PaperCitations, authors & open-access status

New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice is a paper indexed in ScholarIQ from OpenAlex.

How many citations does New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice have?

ScholarIQcitation count

New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice has 162 citations in the OpenAlex counts ScholarIQ stores.

When was New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice published?

ScholarIQyear

New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice has 2019 year in the ScholarIQ index.

What is the open-access status of New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice?

ScholarIQoa status

New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice has green oa status in the ScholarIQ index.

What is the DOI of New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice?

ScholarIQdoi

The DOI for New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice is on the source record.

What is the PMID of New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice?

ScholarIQpmid

The PMID for New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice is on the source record.

What is the OpenAlex record for New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice?

ScholarIQopenalex

The OpenAlex for New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial